Regencell Bioscience Holdings Ltd
- Last sale
- Nov 12, 2026 · -6.24%
- Market cap
- $2.53B
- 495.88M shares
- Filings
- 86
—
—
—FY 2026N/M FY26 yoy
FY 2026N/M FY26 yoy
FY 2025derivedN/M FY25 yoy
FY 2026N/M FY26 yoy
FY 2026+486.7% FY26 yoy
- $2.53B
- —
- —
- 189.8×
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $1,299,627 | reported | |
| FY 2025 | 2025-06-30 | $948,289 | reported | |
| FY 2024 | 2024-06-30 | $1,066,233 | reported | |
| FY 2023 | 2023-06-30 | $1,581,628 | reported | |
| FY 2022 | 2022-06-30 | $2,512,154 | reported | |
| FY 2021 | 2021-06-30 | $438,323 | reported | |
| FY 2020 | 2020-06-30 | $386,230 | reported | |
| FY 2019 | 2019-06-30 | $228,223 | reported |
Medicinal chemicals & botanical products
Regencell Bioscience Holdings Ltd is the 2nd largest of the 41 covered companies the SEC files under this code, by market cap. SIC 2833
CompanyRevenueGrowthNet marginMarket cap
DFTXDefinium Therapeutics, Inc.———$4.5B
RGCRegencell Bioscience Holdings Ltd (this company)———$2.5B
CURLFCuraleaf Holdings, Inc.$1.3B5.0%18.2%$2.3BTRLVTrulieve Cannabis Corp.$1.2B0.4%9.9%$1.9BCRONCronos Group Inc.$146.6M24.6%6.4%$1.3BTLRYTilray Brands, Inc.$915.5M11.5%13.3%$368.7MSNDLSNDL Inc.———$367.4MACBAurora Cannabis Inc———$294.4MCGCCanopy Growth Corp———$244.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Regencell Bioscience Holdings Ltd · CIK 1829667 · Engraved from SEC EDGAR